Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer

Published:2022-09-28 Issue:19 Volume:14 Page:4714
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Huang Jinyong,Du Meijun,Soupir Alex^ORCID,Wang Liewei,Tan Winston,Kalari Krishna R.,Kilari Deepak,Park Jong^ORCID,Huang Chiang-Ching^ORCID,Kohli Manish^ORCID,Wang Liang^ORCID

Abstract

Prostate cancer (PCa) accounted for more than 34,000 deaths in US males [...]

Funder

National Institute of Health

National Institutes of Health

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/14/19/4714/pdf

Reference42 articles.

1. Cancer Statistics, 2021

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

4. Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective

5. A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate–prednisone

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review;European Urology Oncology;2024-05